Related Experiment Videos
Gene expression changes in response to E2F1 activation
Jens Stanelle1, Thorsten Stiewe, Carmen C Theseling
1Centre for Cancer Research and Cancer Therapy, Institute of Molecular Biology, University of Essen, Medical School, Hufelandstrasse 55, D-45122 Essen, Germany.
Abstract:
The p16/RB/E2F regulatory pathway, which controls transit through the G1 restriction point of the cell cycle, is one of the most frequent targets of genetic alterations in human cancer. Any of these alterations results in the deregulated expression of the transcription factor E2F, one of the key mediators of cell cycle progression. Under these conditions, E2F1 also participates in the induction of apoptosis by a p53-dependent pathway, and independently of p53. Recently, we identified the p53-homolog p73 as a first direct target of p53-independent apoptosis. Here, we used a cDNA microarray to screen an inducible E2F1-expressing Saos-2 cell line for E2F1 target genes. Expression analysis by cDNA microarray and RT-PCR revealed novel E2F1 target genes involved in E2F1-regulated cellular functions such as cell cycle control, DNA replication and apoptosis. In addition, the identification of novel E2F1 target genes participating in the processes of angiogenesis, invasion and metastasis supports the view that E2F1 plays a central role in many aspects of cancer development. These results provide new insight into the role of E2F1 in tumorigenesis as a basis for the development of novel anti-cancer therapeutics.
Insights
The study identifies new genes regulated by E2F1, a key factor in cell cycle control and cancer development. These findings offer insights into E2F1
Area of Science:
- Molecular Biology
- Cancer Research
- Cell Cycle Regulation
Background:
- The p16/RB/E2F pathway is frequently altered in human cancers, leading to dysregulated E2F transcription factor expression.
- E2F1 plays a role in cell cycle progression and can induce apoptosis both dependently and independently of p53.
- The p53 homolog, p73, was previously identified as a direct target of p53-independent apoptosis.
Purpose of the Study:
- To identify novel E2F1 target genes using a cDNA microarray screen.
- To investigate the role of E2F1 in various cellular functions relevant to cancer development.
Main Methods:
- Screening of an inducible E2F1-expressing Saos-2 cell line using cDNA microarray.
- Expression analysis of identified genes via cDNA microarray and reverse transcription-polymerase chain reaction (RT-PCR).
Main Results:
- Identified novel E2F1 target genes involved in cell cycle control, DNA replication, and apoptosis.
- Discovered E2F1 target genes implicated in angiogenesis, invasion, and metastasis.
- Confirmed E2F1's central role in multiple facets of cancer development.
Conclusions:
- E2F1 regulates a broad spectrum of genes critical for cellular functions and cancer progression.
- The findings provide new insights into E2F1's role in tumorigenesis.
- These results may form the basis for developing novel anti-cancer therapeutics targeting E2F1.